We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+14.21%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$987M
AUM Growth
+$120M
(+14%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.71M |
| 2 |
DexCom
DXCM
|
+$6.59M |
| 3 |
X
US Steel
X
|
+$6.1M |
| 4 |
CMBT
CMB.TECH NV
CMBT
|
+$5.09M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$4.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GOOS
Canada Goose Holdings
GOOS
|
+$21.9M |
| 2 |
Constellation Brands
STZ
|
+$9.52M |
| 3 |
Lumen
LUMN
|
+$7.13M |
| 4 |
Weyerhaeuser
WY
|
+$6.3M |
| 5 |
FedEx
FDX
|
+$6.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.75% |
| 2 | Technology | 15.19% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.06% |
| 5 | Financials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Tandem Diabetes Care
TNDM
$1.29B
| $562K | 0.06% |
+8,855
| New | +$465K |
|
627
Antero Resources
AR
$10.7B
| $560K | 0.06% |
63,450
-4,535
| -7% | -$42.8K |
|
628
Vericel Corp
VCEL
$2.29B
| $559K | 0.06% |
31,944
-7,556
| -19% | -$138K |
|
|
MIK
629
DELISTED
Michaels Stores, Inc
MIK
| $559K | 0.06% |
48,965
-16,911
| -26% | -$232K |
|
|
GRMN
630
Garmin
GRMN
$58.2B
| $558K | 0.06% |
+6,460
| New | +$486K |
|
631
Macy's
M
$6.61B
| $558K | 0.06% |
23,226
-11,474
| -33% | -$290K |
|
|
CBPX
632
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $557K | 0.06% |
22,451
+4,123
| +22% | +$108K |
|
633
STAAR Surgical
STAA
$1.15B
| $555K | 0.06% |
16,239
-46,517
| -74% | -$1.65M |
|
634
SandRidge Energy
SD
$496M
| $554K | 0.06% |
69,081
+40,850
| +145% | +$334K |
|
635
Kelly Services Class A
KELYA
$542M
| $553K | 0.06% |
25,089
+4,183
| +20% | +$95.8K |
|
|
NSA
636
DELISTED
National Storage Affiliates Trust
NSA
| $551K | 0.06% |
19,319
+3,911
| +25% | +$108K |
|
637
Pediatrix Medical
MD
$2.15B
| $550K | 0.06% |
+20,227
| New | +$678K |
|
638
Nucor
NUE
$61.9B
| $547K | 0.06% |
+9,373
| New | +$550K |
|
|
AVP
639
DELISTED
Avon Products, Inc.
AVP
| $547K | 0.06% |
186,185
-511,611
| -73% | -$1.29M |
|
640
PC Connection
CNXN
$2.19B
| $545K | 0.06% |
14,866
+7,417
| +100% | +$267K |
|
641
Dolby
DLB
$5.71B
| $545K | 0.06% |
+8,656
| New | +$553K |
|
642
HUB Group
HUBG
$2.83B
| $545K | 0.06% |
26,682
+3,314
| +14% | +$70.7K |
|
643
Western Alliance Bancorporation
WAL
$8.87B
| $545K | 0.06% |
+13,285
| New | +$585K |
|
644
Fidelity National Information Services
FIS
$22.1B
| $543K | 0.06% |
+4,797
| New | +$511K |
|
645
Dorian LPG
LPG
$1.9B
| $543K | 0.06% |
84,551
+40,835
| +93% | +$239K |
|
646
Unitil
UTL
$981M
| $542K | 0.05% |
+9,997
| New | +$522K |
|
647
Terreno Realty
TRNO
$7.43B
| $539K | 0.05% |
+12,822
| New | +$513K |
|
|
CIO
648
DELISTED
City Office REIT
CIO
| $538K | 0.05% |
+47,563
| New | +$542K |
|
|
FLNT
649
Fluent
FLNT
$114M
| $538K | 0.05% |
15,961
-1,322
| -8% | -$39K |
|
|
BGFV
650
DELISTED
Big 5 Sporting Goods
BGFV
| $537K | 0.05% |
168,983
+53,989
| +47% | +$195K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2019 Portfolio in Review
As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.
- GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
- GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
- GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
- GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
- GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
- GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
- GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.
Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.